首页|儿童注意缺陷多动障碍患儿应用盐酸哌甲酯治疗对其依从性的影响

儿童注意缺陷多动障碍患儿应用盐酸哌甲酯治疗对其依从性的影响

扫码查看
目的 分析儿童注意缺陷多动障碍患儿应用盐酸哌甲酯治疗的临床效果及对其用药依从性的影响。方法 选取本院收治的 60 例注意缺陷多动障碍患儿,按随机数字表法分为观察组与对照组,各 30 例。对照组服用速释盐酸哌甲酯片治疗,观察组服用盐酸哌甲酯缓释片治疗。比较两组治疗效果、依从性、用药前后的中文版评定量表父母版(SNAP-Ⅳ)评分(注意力不足评分、多动/冲动评分、对立违抗评分)、用药前后的血清学指标[泌乳素(PRL)、中枢神经特异性蛋白(S100β)]、不良反应发生情况。结果 两组治疗总有效率比较无差异(P>0。05)。两组用药 1 个月的依从性比较无差异(P>0。05)。观察组用药 3、6、12 个月时的依从性分别为 93。33%、90。00%、90。00%,高于对照组的 66。67%、60。00%、60。00%(P<0。05)。用药后,两组患儿的注意力不足、多动/冲动、对立违抗评分均有所降低,且观察组注意力不足、多动/冲动、对立违抗评分分别为(10。36±1。24)、(9。86±1。12)、(8。14±1。04)分,低于对照组的(13。41±1。38)、(12。93±1。20)、(10。06±1。10)分(P<0。05)。用药后,两组PRL、S100β高于用药前,且观察组PRL、S100β分别为(11。15±1。58)、(42。51±4。10)ng/ml,高于对照组的(8。96±1。37)、(35。08±3。93)ng/ml(P<0。05)。观察组不良反应发生率为13。33%,对照组不良反应发生率为23。33%,比较差异无统计学意义(P>0。05)。结论 盐酸哌甲酯缓释片可改善注意缺陷多动障碍患儿的临床症状,增加用药依从性。
Effect of methylphenidate hydrochloride on compliance in children with attention deficit hyperactivity disorder
Objective To analyze the clinical effect of methylphenidate hydrochloride in children with attention deficit hyperactivity disorder and its influence on medication compliance.Methods 60 children with attention deficit hyperactivity disorder in our hospital were selected and divided into an observation group and a control group according to random number table method,with 30 cases in each group.The control group was treated with rapid-release methylphenidate hydrochloride tablets,and the observation group was treated with methylphenidate hydrochloride prlonged-release tablets.Both groups were compared in terms of therapeutic effect,compliance,Swanson Nolan and Pelham Version Ⅳ Scale(SNAP-Ⅳ)score(attention deficit score,hyperactivity/impulsivity score,oppositional defiant score),serological indicators[prolactin(PRL),soluble protein-100β(S100β)]before and after medication,and occurrence of adverse reactions.Results There was no difference in the total effective rate between the two groups(P>0.05).There was no difference in compliance between the two groups after 1 month of medication(P>0.05).The compliance of the observation group after 3,6 and 12 months of medication were 93.33%,90.00%and 90.00%,which were higher than 66.67%,60.00%and 60.00%of the control group(P<0.05).After medication,the scores of attention deficit,hyperactivity/impulsivity,oppositional defiance decreased in both groups;the scores of attention deficit,hyperactivity/impulsivity and oppositional defiance in the observation group were(10.36±1.24),(9.86±1.12)and(8.14±1.04)points,which were lower than(13.41±1.38),(12.93±1.20)and(10.06±1.10)points in the control group(P<0.05).After treatment,PRL and S100β in both groups were higher than those before treatment;PRL and S100β in the observation group were(11.15±1.58)and(42.51±4.10)ng/ml,which were higher than(8.96±1.37)and(35.08±3.93)ng/ml in the control group(P<0.05).The incidence of adverse reactions of the observation group was 13.33%,and that of the control group was 23.33%.There was no statistically significant difference between the two groups(P>0.05).Conclusion Methylphenidate hydrochloride tablets can improve the clinical symptoms of children with attention deficit hyperactivity disorder,and increase the medication compliance.

Attention deficit hyperactivity disorderMethylphenidate hydrochloride prolonged-release tabletsRapid-release tabletsCompliance

李伟伟

展开 >

252500 冠县新华医院儿科

注意缺陷多动障碍 盐酸哌甲酯缓释片 速释片 依从性

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(5)
  • 13